These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 1228411
21. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer. Falkson G, van Eden EB, Falkson HC. Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974 [No Abstract] [Full Text] [Related]
22. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma. Costanza ME, Nathanson L, Costello WG, Wolter J, Brunk SF, Colsky J, Hall T, Oberfield RA, Regelson W. Cancer; 1976 Apr; 37(4):1654-9. PubMed ID: 769936 [Abstract] [Full Text] [Related]
23. Combination chemotherapy for disseminated malignant melanoma. Costanzi JJ, Vaitkevicius VK, Quagliana JM, Hoogstraten B, Coltman CA, Delaney FC. Cancer; 1975 Feb; 35(2):342-6. PubMed ID: 1111912 [Abstract] [Full Text] [Related]
24. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM. Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [Abstract] [Full Text] [Related]
25. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man. van Eden EB, Falkson G, van Dyk JJ, van der Merwe AM, Falkson HC. Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803 [No Abstract] [Full Text] [Related]
26. A controlled clinical trial of fluorouracil plus imidazole carboxamide dimethyl triazeno plus vincristine plus bis-chloroethyl nitrosourea plus radiotherapy in stomach cancer. Falkson G, van Eden EB. Med Pediatr Oncol; 1976 Feb; 2(2):111-7. PubMed ID: 785197 [Abstract] [Full Text] [Related]
27. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide. Azizi F, Bitran J, Javehari G, Herbst AL. Am J Obstet Gynecol; 1979 Feb 15; 133(4):379-81. PubMed ID: 433999 [Abstract] [Full Text] [Related]
29. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388). Carbone PP, Costello W. Cancer Treat Rep; 1976 Feb 15; 60(2):193-8. PubMed ID: 769973 [Abstract] [Full Text] [Related]
30. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study. Eyre HJ, Eltringham JR, Gehan EA, Vogel FS, Al-Sarraf M, Talley RW, Costanzi JJ, Athens JW, Oishi N, Fletcher WS. Cancer Treat Rep; 1986 Sep 15; 70(9):1085-90. PubMed ID: 3017551 [Abstract] [Full Text] [Related]
31. Influence of therapy on the antioxidant status in patients with melanoma. Gadjeva V, Dimov A, Georgieva N. J Clin Pharm Ther; 2008 Apr 15; 33(2):179-85. PubMed ID: 18315784 [Abstract] [Full Text] [Related]
32. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma. Mitchell MS, Mokyr MB, Davis JM. J Clin Invest; 1977 Jun 15; 59(6):1017-26. PubMed ID: 863999 [Abstract] [Full Text] [Related]
33. Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations. Klener P, Donner L. Acta Haematol; 1977 Jun 15; 57(5):272-8. PubMed ID: 66832 [Abstract] [Full Text] [Related]
34. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma]. Kogoniia LM, Moroz LV, Perevodchikova NI, Platinskiĭ LV, Borisov AI. Vopr Onkol; 1981 Jun 15; 27(4):16-21. PubMed ID: 7015692 [Abstract] [Full Text] [Related]
35. Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Susens GP, Hendrickson C, Barto DA, Sams BJ. Ann Intern Med; 1976 Feb 15; 84(2):175-6. PubMed ID: 1252046 [No Abstract] [Full Text] [Related]
36. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Ahmann DL, Bisel HF, Edmonson JH, Hahn RG, Eagan RT, O'Connell MJ, Frytak S. Clin Pharmacol Ther; 1976 Jun 15; 19(6):821-4. PubMed ID: 773589 [Abstract] [Full Text] [Related]
37. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group. Johnson RO, Metter G, Wilson W, Hill G, Krementz E. Cancer Treat Rep; 1976 Feb 15; 60(2):183-7. PubMed ID: 769971 [Abstract] [Full Text] [Related]
38. DTIC (NSC-45388) in malignant melanoma: a perspective. Comis RL. Cancer Treat Rep; 1976 Feb 15; 60(2):165-76. PubMed ID: 769969 [No Abstract] [Full Text] [Related]
39. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. Flory AB, Rassnick KM, Al-Sarraf R, Bailey DB, Balkman CE, Kiselow MA, Autio K. J Vet Intern Med; 2008 Feb 15; 22(1):164-71. PubMed ID: 18289305 [Abstract] [Full Text] [Related]
40. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4]. Brunner KW, Maurice P, Sonntag RW. Schweiz Med Wochenschr; 1972 Oct 28; 102(43):1546-51. PubMed ID: 4647016 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]